Coho Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.18M | Sell |
48,227
-38,361
| -44% | -$1.79M | 0.28% | 31 |
|
|
2025
Q2 | $4.01M | Buy |
86,588
+15,785
| +22% | +$775K | 0.3% | 32 |
|
|
2025
Q1 | $4.32M | Buy |
+70,803
| New | +$4.13M | 0.26% | 33 |
|
|
2024
Q2 | – | Sell |
-10,040
| Closed | -$544K | – | 47 |
|
|
2024
Q1 | $544K | Buy |
10,040
+40
| +0.4% | +$2.04K | 0.01% | 55 |
|
|
2023
Q4 | $513K | Hold |
10,000
| – | – | 0.01% | 63 |
|
|
2023
Q3 | $580K | Hold |
10,000
| – | – | 0.01% | 52 |
|
|
2023
Q2 | $640K | Hold |
10,000
| – | – | 0.01% | 52 |
|
|
2023
Q1 | $693K | Hold |
10,000
| – | – | 0.01% | 54 |
|
|
2022
Q4 | $719K | Hold |
10,000
| – | – | 0.01% | 57 |
|
|
2022
Q3 | $711K | Hold |
10,000
| – | – | 0.01% | 50 |
|
|
2022
Q2 | $770K | Hold |
10,000
| – | – | 0.01% | 49 |
|
|
2022
Q1 | $730K | Hold |
10,000
| – | – | 0.01% | 51 |
|
|
2021
Q4 | $623K | Sell |
10,000
-1,400
| -12% | -$82.1K | 0.01% | 58 |
|
|
2021
Q3 | $675K | Hold |
11,400
| – | – | 0.01% | 48 |
|
|
2021
Q2 | $762K | Hold |
11,400
| – | – | 0.01% | 47 |
|
|
2021
Q1 | $720K | Hold |
11,400
| – | – | 0.01% | 48 |
|
|
2020
Q4 | $707K | Hold |
11,400
| – | – | 0.01% | 47 |
|
|
2020
Q3 | $687K | Sell |
11,400
-217
| -2% | -$13.1K | 0.01% | 43 |
|
|
2020
Q2 | $683K | Buy |
11,617
+217
| +2% | +$13K | 0.01% | 44 |
|
|
2020
Q1 | $635K | Hold |
11,400
| – | – | 0.02% | 45 |
|
|
2019
Q4 | $732K | Buy |
11,400
+800
| +8% | +$45.8K | 0.02% | 51 |
|
|
2019
Q3 | $538K | Hold |
10,600
| – | – | 0.01% | 45 |
|
|
2019
Q2 | $481K | Hold |
10,600
| – | – | 0.01% | 41 |
|
|
2019
Q1 | $506K | Buy |
10,600
+600
| +6% | +$29.9K | 0.01% | 39 |
|
|
2018
Q4 | $520K | Hold |
10,000
| – | – | 0.01% | 40 |
|
|
2018
Q3 | $621K | Hold |
10,000
| – | – | 0.01% | 39 |
|
|
2018
Q2 | $553K | Hold |
10,000
| – | – | 0.01% | 39 |
|
|
2018
Q1 | $632K | Sell |
10,000
-1,100
| -10% | -$70.8K | 0.02% | 39 |
|
|
2017
Q4 | $680K | Hold |
11,100
| – | – | 0.02% | 37 |
|
|
2017
Q3 | $708K | Hold |
11,100
| – | – | 0.02% | 35 |
|
|
2017
Q2 | $618K | Hold |
11,100
| – | – | 0.02% | 38 |
|
|
2017
Q1 | $604K | Hold |
11,100
| – | – | 0.02% | 35 |
|
|
2016
Q4 | $649K | Hold |
11,100
| – | – | 0.02% | 37 |
|
|
2016
Q3 | $599K | Hold |
11,100
| – | – | 0.02% | 40 |
|
|
2016
Q2 | $816K | Hold |
11,100
| – | – | 0.03% | 42 |
|
|
2016
Q1 | $709K | Hold |
11,100
| – | – | 0.03% | 40 |
|
|
2015
Q4 | $764K | Hold |
11,100
| – | – | 0.03% | 40 |
|
|
2015
Q3 | $657K | Buy |
11,100
+400
| +4% | +$25.4K | 0.03% | 42 |
|
|
2015
Q2 | $712K | Buy |
10,700
+700
| +7% | +$46.1K | 0.04% | 35 |
|
|
2015
Q1 | $645K | Hold |
10,000
| – | – | 0.03% | 35 |
|
|
2014
Q4 | $590K | Hold |
10,000
| – | – | 0.03% | 35 |
|
|
2014
Q3 | $512K | Hold |
10,000
| – | – | 0.03% | 32 |
|
|
2014
Q2 | $485K | Hold |
10,000
| – | – | 0.03% | 33 |
|
|
2014
Q1 | $519K | Hold |
10,000
| – | – | 0.04% | 33 |
|
|
2013
Q4 | $531K | Hold |
10,000
| – | – | 0.04% | 33 |
|
|
2013
Q3 | $463K | Hold |
10,000
| – | – | 0.04% | 35 |
|
|
2013
Q2 | $447K | Buy |
+10,000
| New | +$434K | 0.04% | 35 |
|
Other funds holding BMY
Coho Partners's BMY Position: Q3 2025 in Review
Coho Partners reduced its Bristol-Myers Squibb (BMY) stake by 44% in Q3 2025, selling an estimated $1.79M and leaving 48,227 shares worth $2.18M. The position accounts for 0.28% of the portfolio, ranked #31.
Coho Partners first reported a position in BMY in Q2 2013 and has held it in 47 quarters since. The position peaked at $4.32M in Q1 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Coho Partners held 48,227 shares of Bristol-Myers Squibb worth $2.18M as of Q3 2025.
- Coho Partners sold 38,361 Bristol-Myers Squibb shares in Q3 2025, an estimated $1.79M.
- Bristol-Myers Squibb made up 0.28% of Coho Partners's portfolio in Q3 2025, its #31 holding.
- Coho Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 47 quarters since.
- Coho Partners's Bristol-Myers Squibb position peaked at $4.32M in Q1 2025.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Coho Partners's 13F filing for Q3 2025, filed 14 Oct 2025.